Latest News and Press Releases
Want to stay updated on the latest news?
-
21 December 2023, 18:00 CET With reference to Article 19(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse...
-
WISeKey Subsidiaries, WISe.ART and SEALSQ, Partner with Paolina Art, artist Ylan Anoufa, and Clos de Lunes wines of Bordeaux, On Counterfeit Protection Venture Geneva – December 21, 2023:...
-
WISeKey y Autoridad Portuaria de Algeciras se unen en un proyecto Pionero de transformación digital Ginebra, Suiza; Algeciras, España, el 21 de diciembre 2023, WISeKey International Holding Ltd....
-
WISeKey and The Port Authority of Algeciras Join Forces in Pioneering Digital Transformation Project
WISeKey and The Port Authority of Algeciras Join Forces in Pioneering Digital Transformation Project Picture: Carlos Moreira, president of WISeKey and founder of the company, signed this agreement...
-
Ad hoc-Mitteilung gemäss Art. 53 des SIX Kotierungsreglements (KR) Schweiter Technologies stärkt sein Architekturgeschäft Schweiter Technologies erwirbt 60% an Jiangsu ZNL Coating New...
-
Ad hoc announcement pursuant to Art. 53 of the SIX Listing Rules (LR) Schweiter Technologies strengthens its architecture business Schweiter Technologies acquired 60% of Jiangsu ZNL Coating New...
-
Kuntarahoitus OyjPörssitiedote20.12.2023 klo 10.00 Kuntarahoitus laskee liikkeeseen 10 miljoonan euron joukkovelkakirjalainan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee liikkeeseen...
-
Municipality Finance PlcStock exchange release 20 December 2023 at 10:00 am (EET) Municipality Finance issues EUR 10 million notes under its MTN programme Municipality Finance Plc issues EUR 10...
-
Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 20. Dezember 2023 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem...
-
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, December 20, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...